Hoth Therapeutics (HOTH) SEC Filings & 10K Form

$1.16
-0.01 (-0.85%)
(As of 01:18 PM ET)

Recent Hoth Therapeutics SEC Filings

DateFilerForm TypeView
04/22/2024
3:15 PM
Hoth Therapeutics (Filer)
Form 424B3
04/21/2024
11:15 PM
Hoth Therapeutics (Filer)
Form EFFECT
04/11/2024
3:15 PM
Hoth Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2024
3:07 PM
Hoth Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
6:15 AM
Hoth Therapeutics (Filer)
Form 424B3
03/28/2024
6:00 AM
Hoth Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:47 PM
ARMISTICE CAPITAL, LLC (Filed by)
Hoth Therapeutics (Subject)
Form SC 13G/A
01/09/2024
2:03 PM
Hoth Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:00 PM
Hoth Therapeutics (Issuer)
Knie Robb (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:01 PM
Hoth Therapeutics (Issuer)
Linsley Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:01 PM
Hoth Therapeutics (Issuer)
Pavell Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:01 PM
Hoth Therapeutics (Issuer)
Sarnoff David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:01 PM
Hoth Therapeutics (Issuer)
Springer Graig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
7:15 AM
Hoth Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
3:15 PM
Hoth Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
4:24 PM
Hoth Therapeutics (Filer)
Form 424B5
08/21/2023
4:10 PM
Hoth Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
7:31 PM
Hoth Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
3:15 PM
Hoth Therapeutics (Issuer)
Linsley Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:15 PM
Hoth Therapeutics (Issuer)
Pavell Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:15 PM
Hoth Therapeutics (Issuer)
Knie Robb (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:15 PM
Hoth Therapeutics (Issuer)
Springer Graig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:15 PM
Hoth Therapeutics (Issuer)
Sarnoff David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
3:20 PM
Hoth Therapeutics (Filer)
Form DEF 14A
06/27/2023
3:22 PM
Hoth Therapeutics (Filer)
Form DEFA14A
06/19/2023
11:15 PM
Hoth Therapeutics (Filer)
Form EFFECT
06/13/2023
4:00 PM
Hoth Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HOTH) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners